Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,679,000 | 4,071,000 | 3,302,000 | 1,703,000 | 2,060,000 |
| Marketable Securities | 1,614,000 | 1,574,000 | 1,461,000 | 1,217,000 | 1,135,000 |
| Receivables | 1,821,000 | 1,818,000 | 1,766,000 | 1,913,000 | 1,759,000 |
| Inventories | 1,406,000 | 1,469,000 | 1,493,000 | 1,425,000 | 1,365,000 |
| Income taxes - deferred | 385,000 | N/A | 614,000 | 292,000 | 272,000 |
| Other current assets | 19,000 | 0 | 0 | 0 | 0 |
| TOTAL | $9,053,000 | $9,577,000 | $8,753,000 | $6,671,000 | $6,699,000 |
| Non-Current Assets | |||||
| PPE Net | 5,266,000 | 5,135,000 | 4,986,000 | 4,758,000 | 4,563,000 |
| Investments And Advances | 1,832,000 | 2,201,000 | 2,090,000 | 1,952,000 | 1,883,000 |
| Intangibles | 2,660,000 | 2,704,000 | 2,745,000 | 2,782,000 | 1,742,000 |
| Other Non-Current Assets | 308,000 | 378,000 | 366,000 | 1,281,000 | 1,472,000 |
| TOTAL | $10,066,000 | $10,418,000 | $10,187,000 | $10,773,000 | $9,660,000 |
| Total Assets | $19,119,000 | $19,995,000 | $18,940,000 | $17,444,000 | $16,359,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 223,000 | 278,000 | 420,000 | 283,000 | 361,000 |
| Accrued Expenses | N/A | 473,000 | 776,000 | N/A | N/A |
| TOTAL | $2,705,000 | $3,657,000 | $3,918,000 | $2,056,000 | $1,989,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,475,000 | 2,460,000 | 2,402,000 | 2,346,000 | 2,307,000 |
| Deferred Revenues | 81,000 | 78,000 | 73,000 | 44,000 | 52,000 |
| Other Non-Current Liabilities | 250,000 | 348,000 | 297,000 | 1,057,000 | 1,032,000 |
| TOTAL | $3,129,000 | $3,232,000 | $3,117,000 | $3,756,000 | $3,519,000 |
| Total Liabilities | $5,834,000 | $6,889,000 | $7,035,000 | $5,812,000 | $5,508,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,055,650 | 1,050,892 | 1,053,124 | 1,053,092 | 1,053,032 |
| Common Shares | 21,000 | 21,000 | 21,000 | 21,000 | 21,000 |
| Retained earnings | 2,281,000 | 1,717,000 | 992,000 | 557,000 | 1,000 |
| Other shareholders' equity | 105,000 | 123,000 | 197,000 | 212,000 | 205,000 |
| TOTAL | $13,285,000 | $13,106,000 | $11,905,000 | $11,632,000 | $10,851,000 |
| Total Liabilities And Equity | $19,119,000 | $19,995,000 | $18,940,000 | $17,444,000 | $16,359,000 |